Feb 2026· Cardiology Journal· Vol 33· 0 citations· 44 references
Medicine
TL;DR
Current guideline recommendations support aortic valve repair in selected patients with severe AR at experienced centers when durable results are expected and recommend valve-sparing root replacement in young patients with aortic root dilation.
Abstract
Aortic valve repair (AVr) has evolved into a reproducible surgical strategy for selected patients with aortic regurgitation (AR), offering preservation of native tissue, avoidance of prosthesis-related complications, and favorable long-term outcomes when performed at expert centers. This narrative review summarizes contemporary concepts, indications, preoperative imaging work-up, and procedure selection for AVr in tricuspid (TAV) and bicuspid (BAV) aortic valves, with an emphasis on functional mechanisms and standardized annular and root stabilization. Recent international guidelines and key surgical series and registries addressing aortic valve repair, valve-sparing root replacement (VSRR), annuloplasty strategies, and bicuspid repair techniques were reviewed. Modern AVr is anchored in mechanism-based diagnosis of AR, systematic correction of cusp pathology, and stabilization of the functional aortic annulus (FAA), including the virtual basal ring, sinotubular junction, and aortic root. Current guideline recommendations support aortic valve repair in selected patients with severe AR at experienced centers when durable results are expected and recommend valve-sparing root replacement in young patients with aortic root dilation. Quantitative intraoperative quality control, including effective height targets, and durable annular stabilization are key determinants of repair longevity. AVr and VSRR represent mature surgical options for carefully selected patients with AR, particularly younger individuals with good cusp tissue and access to high-volume repair expertise. A mechanism-driven algorithm, including BAV-specific geometry restoration approaches such as the 180-degree reimplantation technique, may clarify the optimal procedure for each clinical scenario.
Aortic valve pathology remains one of the most common causes of cardiovascular morbidity and mortality. Our current understanding of aortic valve disease has changed significantly in recent decades due to advances in imaging techniques, refinements in surgical technologies, and the emergence of reconstructive and trans...
Kamran Ahmadov· Azerbaijan Journal of Cardio...· 0 citations
Background Surgical aortic valve replacement (SAVR) remains the standard treatment for many patients with severe aortic valve disease. Implantation of a small prosthetic valve may result in prosthesis-patient mismatch (PPM), which adversely affects postoperative valve hemodynamics and long-term outcomes. Aortic root en...
The combination of RDV and a minimally invasive approach proved to be safe, with low morbidity and mortality and excellent short-term hemodynamic improvement.
Tomás D'Angelo, Germán A. Fortunato, Martín Chrabalowski et al.· Revista Argentina de Cardiol...· 0 citations
Transcatheter aortic valve implantation (TAVI) has expanded from a treatment for inoperable and high-risk aortic stenosis (AS) to an established therapeutic option for selected patients at low surgical risk; this review focuses on the outcomes of major trials comparing TAVI to traditional surgical aortic valve replacem...
Kelly Wright, Arafat Rahman, Georgia Penny et al.· Expert Review of Cardiovascu...· 0 citations
A sternum-sparing, minimally invasive AVR program using the Stonehenge technique with a TAV-in-SAV-oriented strategy for annular and root enlargement and STJ enlargement with tilt minimization may improve future TAV-in-SAV feasibility while preserving the surgical AVR benefits.
Masataka Yamazaki, Yorihiko Matsumoto, Hirofumi Haida et al.· Surgery today (Print)· 0 citations
Transcatheter aortic valve replacement (TAVR) has transformed the treatment of severe aortic stenosis across all surgical risk profiles. However, as TAVR expands into younger, lower-risk populations with longer life expectancies, the management of late bioprosthetic failure has emerged as a critical clinical challenge....
Berk İnan, F. Iqbal, M. Tagliafierro et al.· Cardiology in Review· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.